WCM Investment Management
PCVX icon

WCM Investment Management’s Vaxcyte PCVX Stock Holding History

WCM Investment Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
243,502
+130,871
+116% +$7.11M 0.03% 131
2026
Q1 		$6.19M Buy
+112,631
New +$6.11M 0.01% 178
2025
Q3 		– Sell
-70,372
Closed -$2.29M – 246
2025
Q2 		$2.29M Sell
70,372
-1,105
-2% -$36.2K 0.01% 187
2025
Q1 		$4.96M Sell
71,477
-617
-0.9% -$49.3K 0.01% 168
2024
Q4 		$5.91M Sell
72,094
-68,753
-49% -$6.83M 0.01% 170
2024
Q3 		$15.9M Buy
140,847
+48,543
+53% +$4.37M 0.04% 117
2024
Q2 		$7.27M Buy
+92,304
New +$6.28M 0.02% 152

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

WCM Investment Management's PCVX Position: Q2 2026 in Review

WCM Investment Management increased its Vaxcyte (PCVX) stake by 116% in Q2 2026, buying an estimated $7.11M and bringing the position to 243,502 shares worth $14.1M. The position accounts for 0.03% of the portfolio, ranked #131.

WCM Investment Management first reported a position in PCVX in Q2 2024 and has held it in 7 quarters since. The position peaked at $15.9M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • WCM Investment Management held 243,502 shares of Vaxcyte worth $14.1M as of Q2 2026.
  • WCM Investment Management bought 130,871 Vaxcyte shares in Q2 2026, an estimated $7.11M.
  • Vaxcyte made up 0.03% of WCM Investment Management's portfolio in Q2 2026, its #131 holding.
  • WCM Investment Management first reported a position in Vaxcyte in Q2 2024 and has held it in 7 quarters since.
  • WCM Investment Management's Vaxcyte position peaked at $15.9M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on WCM Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.